Medical center people
Ron Levy
Paul Yock
Ron Levy, MD, the Robert K. and Helen K. Summy Professor and chief of the division of oncology, has been awarded the 2007 de Villiers International Achievement Award presented by the Leukemia & Lymphoma Society—a voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The award recognizes Levy's groundbreaking advances in the area of immunotherapies. In the 1970s, Levy and his team were the first to treat lymphoma successfully with a monoclonal antibody to improve survival of patients. That discovery led to the 1997 approval of Rituximab, the first monoclonal antibody approved by the FDA for cancer treatment. Levy will be honored at the Leukemia & Lymphoma Society's Update on ASH Conference on Feb. 2 in San Francisco.
Carlos Milla, MD, has been appointed associate professor of pediatrics, as of Dec. 1. His main area of research centers on the inflammatory responses that lead to airway disease in cystic fibrosis and the metabolic factors that contribute to lung disease progression. He has accumulated substantial experience on the study of longitudinal outcomes in cystic fibrosis and is nationally recognized for his contributions in this area. He is also active in quality improvement, identifying and implementing strategies to improve the clinical outcomes of patients with cystic fibrosis.
Paul Yock, MD, the Martha Meier Weiland Professor in the School of Medicine and professor of bioengineering, is the recipient of the Distinguished Scientist Award of the American College of Cardiology. The award recognizes a fellow of the college who has made major contributions to the advancement of scientific knowledge in the field of cardiovascular disease. Yock has introduced a number of devices that have enhanced patient care by interventional cardiologists, including the original mechanical ultrasound catheter system for imaging of the interior of blood vessels. Yock, who was the founding co-chair of the Department of Bioengineering and serves as director of the Stanford Program in Biodesign, will receive the award during the annual scientific sessions convocation ceremony on March 31.
